Bide Pharmatech Co. Ltd. A (688073) — Cash Flow Quality Index
Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow Quality Index of 0.19x as of December 2025. Operating cash flow of CN¥28.32 Million is below net income of CN¥151.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688073 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bide Pharmatech Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Bide Pharmatech Co. Ltd. A investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for Bide Pharmatech Co. Ltd. A. For live market cap and the full company financial profile, see 688073 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥28.32 Million | CN¥151.74 Million | ▼ -86.2% |
| 2024 | 1.35x | CN¥158.31 Million | CN¥117.43 Million | ▲ +357.4% |
| 2023 | -0.52x | CN¥-57.39 Million | CN¥109.57 Million | ▼ -355.9% |
| 2022 | 0.20x | CN¥29.87 Million | CN¥145.97 Million | ▲ +130.8% |
| 2021 | -0.66x | CN¥-64.88 Million | CN¥97.57 Million | ▼ -1176.4% |
| 2020 | 0.06x | CN¥3.65 Million | CN¥59.00 Million | — |